Dual PI3K/mTOR Inhibitors Induce Rapid Over-Activation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells Through Suppression of mTORC2

被引：0
|
作者：
Soares, H. P.
Xu, Q.
Young, S. H.
Sinnet-Smith, J.
Rozengurt, E.
机构：
[1] Univ Calif Los Angeles, Div Hematol Oncol, Dept Med, David Geffen Sch Med, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, CURE Digest Dis Res Ctr, Los Angeles, CA 90024 USA
来源：
PANCREAS | 2015年 / 44卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1416 / 1416
页数：1
相关论文
共 50 条
  • [1] Dual PI3K/mTOR Inhibitors Induce Rapid Over-Activation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells Through Suppression of mTORC2
    Soares, Heloisa P.
    Ming, Ming
    Young, Steven H.
    Sinnett-Smith, James
    Rozengurt, Enrique
    GASTROENTEROLOGY, 2015, 148 (04) : S949 - S950
  • [2] Dual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2
    Soares, Heloisa P.
    Ming, Ming
    Mellon, Michelle
    Young, Steven H.
    Han, Liang
    Sinnet-Smith, James
    Rozengurt, Enrique
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (04) : 1014 - 1023
  • [3] Targeting PI3K/mTOR leads to MEK/ERK over-activation in pancreatic cancer through suppression of mTORC2
    Soares, Heloisa P.
    Ming, Ming
    Mellon, Michelle
    Young, Steven H.
    Han, Liang
    Sinnet-Smith, James
    Rozengurt, Enrique
    CANCER RESEARCH, 2015, 75
  • [4] Dual targeting of PI3K/mTOR leads to MEK/ERK over-activation in leiomyosarcoma through suppression of mTORC2 inhibition
    Fourneaux, Benjamin
    Chaire, Vanessa
    Karanian, Marie
    Laroche, Audrey
    Italiano, Antoine
    CANCER RESEARCH, 2016, 76
  • [5] Dual mTOR/PI3K inhibitors induce compensatory MEK/ERK activation in human pancreatic cancer cells: A mechanism contributing to drug resistance
    Soares, Heloisa P.
    Ming, Ming
    Sinnett-Smith, James
    Mellon, Michelle
    Rozengurt, Enrique
    CANCER RESEARCH, 2015, 75
  • [6] Suppression of the PI3K/mTOR Pathway Promotes ERK Pathway Activation in Human Pancreatic Cancer Cells
    Soares, H.
    Ming, M.
    Sinnett-Smith, J.
    Rozengurt, E.
    PANCREAS, 2014, 43 (08) : 1409 - 1409
  • [7] Suppression of the mTOR/PI3K Pathway Promotes ERK Pathway Activation in Human Pancreatic Cancer Cells
    Soares, Heloisa P.
    Ming, Ming
    Mellon, Michelle
    Sinnett-Smith, James
    Rozengurt, Enrique
    GASTROENTEROLOGY, 2014, 146 (05) : S872 - S872
  • [8] Potent Suppression of the Growth of Human Pancreatic Cancer Cells by Combinations of Inhibitors of the PI3K/mTOR and MEK/ERK Pathways
    Xu, Qinhong
    Soares, Heloisa
    Young, Steven H.
    Sinnett-Smith, James
    Rozengurt, Enrique
    GASTROENTEROLOGY, 2016, 150 (04) : S330 - S330
  • [9] Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications
    Fourneaux, Benjamin
    Chaire, Vanessa
    Lucchesi, Carlo
    Karanian, Marie
    Pineau, Raphael
    Laroche-Clary, Audrey
    Italiano, Antoine
    ONCOTARGET, 2017, 8 (05) : 7878 - 7890
  • [10] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
12345